FeesSafety
Pluang+

NYSE pre-market update highlights Covenant's defense launch and Moonwalk Bio's RNAi progress.

Market News
09 Sep 2026, 15:55 WIB
PRNewsWire
View Source
Bullish
NYSE pre-market update highlights Covenant's defense launch and Moonwalk Bio's RNAi progress.

The NYSE pre-market update on September 9, 2026, featured key developments including defense company Covenant emerging from stealth with a new factory and heavy-payload weapon system, backed by over $250 million in funding. Moonwalk Bio announced progress in RNAi treatments aimed at reducing body fat while preserving muscle, with clinical trials expected in late 2027. Additionally, Brent Crude oil prices topped $100 a barrel amid Middle East tensions, influencing market outlook ahead of upcoming inflation data. These updates provide insights into defense innovation, biotech advancements, and commodity price shifts impacting investors.

More News (ORCL)

Intuit's steady growth and profitability make it a better long-term buy than Oracle for 2027.

Intuit's steady growth and profitability make it a better long-term buy than Oracle for 2027.

Intuit and Oracle are both strong software companies, but Intuit's focus on consumer and small business financial tools offers more stable growth and profitability. Intuit serves 93 million users with products like TurboTax and QuickBooks, showing 12...

Market News
Neutral
13 hours ago
Intuit favored over Oracle for 2027 due to stable growth, profits, and AI integration despite Oracle's cloud expansion.

Intuit favored over Oracle for 2027 due to stable growth, profits, and AI integration despite Oracle's cloud expansion.

Intuit and Oracle are compared as investment choices for 2027, with Intuit favored for its stable consumer and small business financial software ecosystem, steady revenue growth, and strong profitability. Intuit serves 93 million users with products ...

Market News
Bullish
18 hours ago
Oracle stock drops nearly 70% from peak amid funding and delivery risks for OpenAI contract.

Oracle stock drops nearly 70% from peak amid funding and delivery risks for OpenAI contract.

Oracle's stock has fallen about 70% from its September 2025 peak, closing at $101.19 after seven straight losses. The decline reflects investor concerns over whether Oracle can convert its large backlog into free cash flow and successfully deliver on...

Market News
Bearish
1 day ago
Cerebras reports 55% revenue growth and signs major deals with Microsoft and Oracle.

Cerebras reports 55% revenue growth and signs major deals with Microsoft and Oracle.

Cerebras Systems saw its revenue jump 55% to $210.8 million, driven by strong demand for its AI inference chips and cloud services. The company secured significant deals with Microsoft and Oracle, expanding its customer base that already includes Ope...

Bullish
1 day ago
Nebius stock plunges 7% amid AI cloud selloff as Michael Burry warns on debt risks

Nebius stock plunges 7% amid AI cloud selloff as Michael Burry warns on debt risks

Nebius shares dropped 7%, extending a 47% decline over the past month, amid a broader selloff in AI cloud stocks fueled by concerns over Big Tech spending and debt-heavy neocloud models. Michael Burry highlighted fundamental weaknesses, warning inves...

Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App